These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33156471)

  • 1. Polygenic Risk Score: Clinically Useful Tool for Prediction of Cardiovascular Disease and Benefit from Lipid-Lowering Therapy?
    Arnold N; Koenig W
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):627-635. PubMed ID: 33156471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley TD; Agha AM; Ballantyne CM
    Curr Atheroscler Rep; 2021 Apr; 23(6):28. PubMed ID: 33791884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
    Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
    Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea.
    Song H; Koh Y; Rhee TM; Choi SY; Kang S; Lee SP
    Atherosclerosis; 2022 May; 348():16-24. PubMed ID: 35390551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular Disease.
    Tada H; Takamura M
    J Atheroscler Thromb; 2024 Jul; 31(7):1029-1030. PubMed ID: 38369334
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?
    Roberts MR; Asgari MM; Toland AE
    Br J Dermatol; 2019 Dec; 181(6):1146-1155. PubMed ID: 30908599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype?
    German CA; Shapiro MD
    Curr Atheroscler Rep; 2021 Jun; 23(9):47. PubMed ID: 34181090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint.
    Ikeda M; Saito T; Kanazawa T; Iwata N
    J Hum Genet; 2021 Jan; 66(1):53-60. PubMed ID: 32770057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polygenic risk prediction of common diseases: from epidemiology to clinical application].
    Jansen PR; Broeders MJM; Cornel MC; Meijers-Heijboer H
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Predisposition of Atherosclerotic Cardiovascular Disease in Ancient Human Remains.
    Wurst C; Maixner F; Paladin A; Mussauer A; Valverde G; Narula J; Thompson R; Zink A
    Ann Glob Health; 2024; 90(1):6. PubMed ID: 38273870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer's Disease.
    Vlachakis D; Papakonstantinou E; Sagar R; Bacopoulou F; Exarchos T; Kourouthanassis P; Karyotis V; Vlamos P; Lyketsos C; Avramopoulos D; Mahairaki V
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
    Berman AN; Blankstein R
    Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease.
    Smith JL; Schaid DJ; Kullo IJ
    Curr Atheroscler Rep; 2023 Jun; 25(6):323-330. PubMed ID: 37223852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update.
    Labos C; Thanassoulis G
    Curr Cardiol Rep; 2018 Mar; 20(5):36. PubMed ID: 29574623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could Polygenic Risk Scores Be Useful in Psychiatry?: A Review.
    Murray GK; Lin T; Austin J; McGrath JJ; Hickie IB; Wray NR
    JAMA Psychiatry; 2021 Feb; 78(2):210-219. PubMed ID: 33052393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist.
    Belanger MJ; Kelly EM; Tahir UA; Benson MD
    Cardiol Rev; 2022 Jul-Aug 01; 30(4):206-213. PubMed ID: 33758125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polygenic risk and pleiotropy in neurodegenerative diseases.
    Bellou E; Stevenson-Hoare J; Escott-Price V
    Neurobiol Dis; 2020 Aug; 142():104953. PubMed ID: 32445791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A perspective on genetic and polygenic risk scores-advances and limitations and overview of associated tools.
    Schwarzerova J; Hurta M; Barton V; Lexa M; Walther D; Provaznik V; Weckwerth W
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38770718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications.
    Aragam KG; Natarajan P
    Circ Res; 2020 Apr; 126(9):1159-1177. PubMed ID: 32324503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.
    Vanichakarn P; Hwa J; Stitham J
    Curr Mol Med; 2014; 14(7):849-79. PubMed ID: 25109793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.